Atosiban

by Biosynth

  • HOR-239-50mg | Introduction: Atosiban is the first oxytocin antagonist to be specifically developed for the treatment of preterm labor. Atosiban has a specific mode of action, inhibiting oxytocin-induced uterine contractions by blocking oxytocin receptors in the uterus.
  • HOR-239-50mg | Introduction: Atosiban is the first oxytocin antagonist to be specifically developed for the treatment of preterm labor. Atosiban has a specific mode of action, inhibiting oxytocin-induced uterine contractions by blocking oxytocin receptors in the uterus.
Average lead time: Call for Lead Time
ADD TO CART
Need Assistance?
Jump to Section
Product Description
Specifications
Additional Information
Media
Product Description
Specifications
Inventory Number:
LVTHOR23950MGEA
Part Number:
HOR-239-50mg
Supplier:
Biosynth
Supplier's Lead Time:
Call for Lead Time
Quantity:
1 per EA
Contract Availability:
GSA
Country of Origin:
United States
Additional Information

Contact the GSS Team Today!
GSS-Sales@govsci.com | 800.248.8030 | www.govsci.com

Government Scientific Source

Government Scientific Source is a leading distributor of laboratory products and equipment dedicated to serving federal, state, and local governments.

ISO 9001:2015 Certified
Copyright 2024, Government Scientific Source. All Rights Reserved.